scispace - formally typeset
R

Rik Vandenberghe

Researcher at Allen Institute for Brain Science

Publications -  430
Citations -  26622

Rik Vandenberghe is an academic researcher from Allen Institute for Brain Science. The author has contributed to research in topics: Frontotemporal dementia & Medicine. The author has an hindex of 69, co-authored 355 publications receiving 21180 citations. Previous affiliations of Rik Vandenberghe include Northwestern University & Katholieke Universiteit Leuven.

Papers
More filters
Journal ArticleDOI

Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease.

Niklas Mattsson, +99 more
TL;DR: Apolipoprotein E (APOE) ε4 is the major genetic risk factor for Alzheimer's disease, but its prevalence is unclear because earlier studies did not require biomarker evidence of amyloid β (Aβ) pathology.
Journal ArticleDOI

Convergence between Lesion-Symptom Mapping and Functional Magnetic Resonance Imaging of Spatially Selective Attention in the Intact Brain

TL;DR: For example, this article found that patients with a right inferior parietal lesion were significantly more impaired during contralesional versus ipsilesional orienting when stimuli were bilateral and symmetrical than when stimuli occupied diagonally opposite quadrants or two quadrants within the same hemifield.
Journal ArticleDOI

APP Processing in Human Pluripotent Stem Cell-Derived Neurons Is Resistant to NSAID-Based γ-Secretase Modulation

TL;DR: This work reveals resistance of human neurons to NSAID-based γ-secretase modulation, highlighting the need to validate compound efficacy directly in the human cell type affected by the respective disease.
Journal ArticleDOI

A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort

Daniel Stamate, +58 more
TL;DR: This work sets out to test the performance of metabolites in blood to categorize AD when compared to CSF biomarkers to capture the metabolic complexity in Alzheimer Disease.